2 results match your criteria: "Centre for Rheumatic Children[Affiliation]"
Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study.
Rheumatology (Oxford)
August 2001
Rheumatology Department, University of Milan, Centre for Rheumatic Children, Gaetano Pini Institute, Milan, Italy.
Objective: This open prospective trial was performed in order to assess the efficacy and safety of cyclosporin A in the treatment of patients with juvenile chronic arthritis (JCA).
Methods: Thirty-four of the patients enrolled were affected by systemic-onset disease and seven by chronic anterior uveitis associated with JCA. The cyclosporin dose was usually 3-5 mg/kg per day.
Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years.
J Rheumatol
February 2000
Institute of Rheumatology, Centre for Rheumatic Children, Department of Rheumatology, Milan, Italy.
Objective: To investigate the relationships between systemic onset juvenile idiopathic arthritis disease activity, course of the disease, and functional class according to Steinbrocker.
Methods: The records of all children with systemic onset juvenile arthritis (JA) according to the American College of Rheumatology criteria attending our center since 1971 with a minimum followup period of 3 years were reviewed. A cohort of 80 consecutive patients entered the study: 42 males, 38 females, mean age at onset 6.